China Modern Dairy Holdings Ltd (1117)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 1.390 |
|---|---|
| 52-week range | 0.880 – 1.735 |
| Return, 1 month / 3 months | −13.1% / +11.2% |
| Return, 1 year / 3 years | +13.9% / +88.9% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 50.5% |
| Worst drawdown (1 year) | -44.5% |
| Average daily value traded | 37.17M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Modern Dairy Holdings runs large-scale dairy farms in China and supplies raw milk to processors that turn it into consumer dairy products. The company manages its own herds and farm operations, focusing on milk production for the domestic market. It is based in China and its stock trades on the Hong Kong exchange. Its customers are mainly dairy manufacturers that use the raw milk in their own branded products.
On this site China Modern Dairy Holdings Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 1117, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Modern Dairy Holdings Ltd (1117) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 1.390 on 20 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 271 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.9% and over the last three months it rose 11.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -0.2% | ||
| From 52-week high | -19.7% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.2% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 31.1% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 50.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.5% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 37.17M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | −13.1% |
| 3 months | +11.2% |
| 6 months | +0.0% |
| 1 year | +13.9% |
| 3 years | +88.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.519 / 1.393 |
|---|---|
| Golden / death cross (60 days) | Golden, 28 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.070 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jun 2025 | HKD 0.0133 |
| 14 Jun 2024 | HKD 0.0049 |
| 8 Jun 2023 | HKD 0.0157 |
| 10 Jun 2022 | HKD 0.0306 |
| 4 Jun 2021 | HKD 0.0243 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.